- Twelve states allow screening for maternal depression during well-child visits;
- Twenty-five states recommend screening for maternal depression during well-child visits;
- Six states require screening for maternal depression during well-child visits; and
- Eight states do not have an active maternal depression screening policy in place.
The American Academy of Pediatrics’ (AAP) Bright Futures periodicity schedule, which many states adopted for their Early and Periodic Screening, Diagnostic and Treatment (EPSDT) programs, includes guidance for maternal depression screenings during well-child visits.
- Twenty states follow Bright Futures for maternal depression screening periodicity during well-child visits;
- Twenty-three states have guidance in addition to or in place of Bright Futures;
- Three states have no guidance for frequency of screening;
- Six states allow screenings as medically necessary; and
- Twenty-five states explicitly limit screenings (ranging from one to six screenings a year).
Almost every state with a maternal depression screening policy recommends or requires scientifically validated and standardized tools. Sixteen states allow other caregivers besides mothers to be screened. Eleven states distinguish between positive and negative screens, with different reimbursement codes, modifiers, or requirements for reporting positive screenings. Thirty-two states report a protocol for tracking, referral and follow-up for positive screens.
Ensuring women with an identified need receive treatment is a critical step in the system of care. Medicaid coverage typically ends 60 days postpartum for women who qualify for the program due to their pregnancy. This change in eligibility can make it difficult for providers to track women postpartum and for women to access follow-up treatment for postpartum depression. Several states have implemented policies to extend postpartum coverage, and others, such as Michigan, are also exploring this option to meet women’s health needs and improve maternal and infant outcomes.
Maternal depression screening during well-child visits is one strategy to identify at-risk mothers, but at least twenty-two states have additional strategies to identify and treat postpartum women at risk for depression, including through a State Health Improvement Plan, Title V programs , and other relevant state performance measures or mental health work groups. For more details, explore NASHP’s Maternal Depression Screening Resources
States continue to make progress in identifying maternal depression, and state-specific guidance makes it easier for standardized screening to occur during well-child visits and to ensure systems for necessary connections to treatment. As states focus on maternal depression, maternal mortality, and implications for child and family health, NASHP will continue to track state initiatives to ensure early identification and delivery of treatment.
* The six states with a policy identified since 2018 are Louisiana, Missouri, Oklahoma, Oregon, Utah, and Wyoming.